Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Home
>
News
LATEST NEWS
Study cited by Texas judge in abortion
FDA approves new treatment for advanced prostate cancer
Cancer Drug Selectively Kills Tumor Cells in Preclinical Study
Understanding the Role of Liquid Crystal Polymer in Telecommunication Technology
Interactive Networks For Capturing Gas With High Selectivity
Jun 15, 2023
Study cited by Texas judge in abortion
read more +
Jun 13, 2023
FDA approves new treatment for advanced prostate cancer
read more +
Jun 11, 2023
Cancer Drug Selectively Kills Tumor Cells in Preclinical Study
read more +
Jun 09, 2023
Understanding the Role of Liquid Crystal Polymer in Telecommunication Technology
read more +
Jun 07, 2023
Interactive Networks For Capturing Gas With High Selectivity
read more +
Jun 05, 2023
The Use of AFM for Polymer Science
read more +
Jun 03, 2023
Understanding Battery Types, Components and the Role of Battery Material Testing in Development and Manufacture
read more +
Jun 01, 2023
Artificial Muscles Flex for the First Time: Ferroelectric Polymer Innovation in Robotics
read more +
May 30, 2023
On the evaluation of the carbon dioxide solubility in polymers using gene expression programming
read more +
May 28, 2023
How simple alternative medicines have helped my quality of life
read more +
May 26, 2023
Sosei Heptares Operational Highlights and Consolidated Results for the Second Quarter and First Half of 2023
read more +
May 24, 2023
Complementary and Alternative Medicine Market to Reach USD 913.82 Billion by 2032; Increased Targeted Investment & Establishing Government Facilities Will Favour Growth: The Brainy Insights
read more +
first
1
2
3
4
5
last